- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 10, 2024 | 16.1M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $19.72M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $87.1M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $11.09M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $15.4M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $38.02M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $45.87M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $79.14M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $92.14M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $79.14M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $92.17M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 15.98M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $7.95M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$38.12M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $181.82M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $351.77M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$10.71 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$10.71 |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $14.43M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$171.72M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$174.17M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $30.81M |
| Revenue | Q1 2024 · Mar 31, 2023 | $189K |